Product image of Orencia 250mg-Bristol (Abatacept ) 250mg Vials supplied by GNH India

Orencia 250mg-Bristol

Active Ingredient:
Abatacept
Form:
Vials
Brand:
ORENCIA
Origin:
Italy

Orencia 250mg-Bristol (Abatacept Vials) 250mg

Abatacept, the active ingredient in Orencia 250mg-Bristol, is a selective T-cell costimulation modulator presented as a 250mg/vial for intravenous use. It is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis in adults and children. GNH India supplies Orencia 250mg-Bristol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH India is a trusted supplier of high-quality pharmaceuticals, ensuring that Orencia 250mg-Bristol meets international standards for safety and efficacy.

Strength

250mg

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Bristol- Myers Squibb

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

Orencia 250mg-Bristol is a disease-modifying antirheumatic drug (DMARD) used to manage inflammatory conditions. It is primarily indicated for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. The drug helps to reduce inflammation, slow disease progression, and improve physical functionality.

  • Rheumatoid arthritis: Reduces joint inflammation and damage, improving physical function.
  • Juvenile idiopathic arthritis: Helps manage symptoms and slow disease progression in children.
  • Psoriatic arthritis: Alleviates joint pain and swelling associated with psoriatic arthritis.

How It Works

  • Abatacept works by selectively modulating the activation of T-cells, which are key players in the immune response. It is a fusion protein that binds to CD80/CD86 receptors on antigen-presenting cells, preventing the CD28-mediated activation of T-cells. This action helps to reduce the inflammatory response and slow the progression of autoimmune diseases.

Side Effects

Orencia 250mg-Bristel may cause side effects, ranging from common to serious. Common Side Effects:

  • Headache
  • Nausea
  • Upper respiratory tract infection
  • Nasopharyngitis
  • Hypercholesterolemia
  • Serious or Rare Side Effects:
  • Increased risk of infections, including serious infections like pneumonia and opportunistic infections.
  • Allergic reactions, including anaphylaxis.
  • Increased risk of malignancies, such as lymphoma and skin cancer.
  • Reactivation of latent viral infections, such as hepatitis B.
  • Gastrointestinal perforations.

Precautions & Warnings

Orencia 250mg-Bristel should be used with caution in certain patient populations. Consult a healthcare provider before use. Precautions include:

  • Infections: Avoid use in patients with active infections or a history of recurrent infections.
  • Immunosuppression: Monitor patients for signs of immunosuppression, as Orencia can increase the risk of infections.
  • Vaccinations: Avoid live vaccines during treatment with Orencia.
  • Hepatitis B: Screen patients for hepatitis B before starting treatment.
  • Pregnancy: Use during pregnancy only if clearly needed, as the safety is not established.
  • Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Orencia 250mg-Bristel may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major Interactions (Avoid):

  • Avoid concomitant use with other biologic DMARDs, as this can increase the risk of infections and other adverse effects.
  • Avoid use with live vaccines, as Orencia can reduce vaccine efficacy and increase the risk of infections.
  • Moderate Interactions (Monitor Closely):
  • Monitor closely when used with corticosteroids, as this can increase the risk of infections and other adverse effects.
  • Monitor closely when used with other immunosuppressants, as this can increase the risk of infections and other adverse effects.

Frequently Asked Questions

Orencia 250mg-Bristel is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. It helps to reduce inflammation, slow disease progression, and improve physical functionality in patients with these conditions.

Abatacept works by selectively modulating the activation of T-cells, which are key players in the immune response. It binds to CD80/CD86 receptors on antigen-presenting cells, preventing the CD28-mediated activation of T-cells, thereby reducing the inflammatory response.

The usual dose of Orencia 250mg-Bristel is determined by a healthcare provider based on the patient's condition and response to treatment. It is typically administered intravenously, and the dosage regimen should be followed as prescribed.

The safety of Orencia 250mg-Bristel during pregnancy has not been established. It should be used during pregnancy only if clearly needed, and the potential benefits and risks should be discussed with a healthcare provider.

To order Orencia 250mg-Bristel from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then provide pricing, availability, shipping, and the necessary import paperwork.

Orencia 250mg-Bristel is a selective T-cell costimulation modulator, which differs from other DMARDs that may target different pathways in the immune system. It is important to consult with a healthcare provider to determine the most appropriate treatment option based on individual patient needs.

Orencia 250mg-Bristel should be stored at 2-8°C, kept refrigerated, protected from light, and not frozen or shaken. Proper storage and handling are crucial to maintain the efficacy and safety of the medication.

Orencia 250mg-Bristel is administered intravenously by a healthcare professional. The dosage and administration schedule should be followed as prescribed by the healthcare provider.

The most serious risks associated with Orencia 250mg-Bristel include an increased risk of infections, including serious infections like pneumonia and opportunistic infections, allergic reactions, increased risk of malignancies, reactivation of latent viral infections, and gastrointestinal perforations.

Orencia 250mg-Bristel should not be used by patients with active infections, a history of recurrent infections, or those who have had an allergic reaction to Abatacept or any of its components. It should be used with caution in patients with a history of hepatitis B or those who are immunocompromised.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.